Stephen A. Hill, Director at Lipocine Inc. (LPCN), sold 1,250 shares at $3.47 ($4K) on 2017-12-29, disclosed to the SEC on 2018-01-02.
Scheduled sale ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2016-04-21 | $20K | — | Filing → |
| CBIO | BUY | 2015-12-18 | $10K | — | Filing → |
| LPCN | BUY | 2014-11-13 | $20K | — | Filing → |